Introduced by Rep. John Espinoza (D) on February 24, 2009, to prohibit a pharmacist to “interchange” (dispense a generic equivalent) for an anti-epilepsy drug without written permission from the prescribing physician.
Referred to the House Health Policy Committee on February 24, 2009.